1. Home
  2. Detail

@maymanthinhvuong: Mệt nhất không phải là chọn sai, mà là sống quá lâu trong sự nửa vời. Muốn bình yên thì học cách an với điều mình chọn. Muốn đi xa thì chấp nhận rèn luyện. Đừng để lời người khác giữ chân mình, cũng đừng để những thói quen cũ quyết định tương lai. Mỗi ngày chỉ cần tiến một bước, sửa một điều, giữ một ranh giới và tử tế hơn với chính mình. Một đời nhẹ hơn bắt đầu từ khi ta dám chọn, dám làm và dám sống theo giá trị của riêng mình. 🌿 #TanVanChuaLanh #SongTinhThuc #TruongThanh #YeuBanThan #BinhYen

Tản Văn Chữa Lành
Tản Văn Chữa Lành
Open In TikTok:
Region: VN
Wednesday 14 October 2026 15:41:13 GMT
2367
169
0
5

Music

Download

No Watermark .mp4 (17.37MB) No Watermark(HD) .mp4 (14.26MB) Watermark .mp4 (20.56MB) Music .mp3

Comments

There are no more comments for this video.
To see more videos from user @maymanthinhvuong, please go to the Tikwm homepage.

Other Videos
#copsoftiktok #policeofficer #fyp #audit #auditor #foryou
#copsoftiktok #policeofficer #fyp #audit #auditor #foryou
GLP-1 receptor agonists are known for diabetes and weight, but a fast-growing body of research suggests they’re also broadly anti-inflammatory and immune-modulating. A 2025 systematic review described effects well beyond metabolism, including emerging interest in autoimmune and neurological conditions. The most direct evidence for MCAS so far is a single 2025 retrospective case series: 47 patients with treatment-resistant MCAS, 89% of whom showed clinical benefit, often within hours to days, across inflammatory, gastrointestinal, neurologic, and autonomic symptoms. Mechanistically, mast cells carry GLP-1 receptors, and these drugs dampen inflammatory pathways like TNF-alpha and NF-kB, which may explain it. The limitations matter and the hype skips them: this was retrospective, single-group, with NO control or placebo, and the authors themselves state that randomized controlled trials are needed before any of this is established. GLP-1 medications are serious prescription drugs with real side effects, real costs, and access issues, and they are NOT a proven or standard MCAS treatment. This is a promising research lead, not a recommendation. I’m not a doctor or scientist. Talk to a clinician who knows your history. Has anyone here been on a GLP-1 and noticed other symptoms change? Curious what you actually experienced. Sources: Afrin LB, Weinstock LB, Dempsey TT, Aschenbrenner K, Blitshteyn S, Schofield JR. Utility of GLP-1 receptor agonists in mast cell activation syndrome. Am J Med Sci. 2025;370(4):377-382. DOI: 10.1016/j.amjms.2025.07.006. Patel S, Niazi SK. Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base. Pharmaceutics. 2025. DOI: 10.3390/pharmaceutics17081036. Alharbi SH. Anti-inflammatory role of GLP-1 receptor agonists and its clinical implications. Ther Adv Endocrinol Metab. 2024. DOI: 10.1177/20420188231222367. #mcas #mastcellactivationsyndrome #glp1 #semiglutide #autoimmune
GLP-1 receptor agonists are known for diabetes and weight, but a fast-growing body of research suggests they’re also broadly anti-inflammatory and immune-modulating. A 2025 systematic review described effects well beyond metabolism, including emerging interest in autoimmune and neurological conditions. The most direct evidence for MCAS so far is a single 2025 retrospective case series: 47 patients with treatment-resistant MCAS, 89% of whom showed clinical benefit, often within hours to days, across inflammatory, gastrointestinal, neurologic, and autonomic symptoms. Mechanistically, mast cells carry GLP-1 receptors, and these drugs dampen inflammatory pathways like TNF-alpha and NF-kB, which may explain it. The limitations matter and the hype skips them: this was retrospective, single-group, with NO control or placebo, and the authors themselves state that randomized controlled trials are needed before any of this is established. GLP-1 medications are serious prescription drugs with real side effects, real costs, and access issues, and they are NOT a proven or standard MCAS treatment. This is a promising research lead, not a recommendation. I’m not a doctor or scientist. Talk to a clinician who knows your history. Has anyone here been on a GLP-1 and noticed other symptoms change? Curious what you actually experienced. Sources: Afrin LB, Weinstock LB, Dempsey TT, Aschenbrenner K, Blitshteyn S, Schofield JR. Utility of GLP-1 receptor agonists in mast cell activation syndrome. Am J Med Sci. 2025;370(4):377-382. DOI: 10.1016/j.amjms.2025.07.006. Patel S, Niazi SK. Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base. Pharmaceutics. 2025. DOI: 10.3390/pharmaceutics17081036. Alharbi SH. Anti-inflammatory role of GLP-1 receptor agonists and its clinical implications. Ther Adv Endocrinol Metab. 2024. DOI: 10.1177/20420188231222367. #mcas #mastcellactivationsyndrome #glp1 #semiglutide #autoimmune
#استوريات #تصميم_فيديوهات🎶🎤🎬 #مشاهير_تيك_توك_مشاهير_العرب #fypシ゚viral #اكسبلورexplore
#استوريات #تصميم_فيديوهات🎶🎤🎬 #مشاهير_تيك_توك_مشاهير_العرب #fypシ゚viral #اكسبلورexplore
[ #ROSA it’s been soo long since I’ve edited her, missed mother :3 Sp: @Nightie @Bayolina Tags: #bayoedit#bayonettaedits#umbrawitches#viral#bayonetta#umbrawitch#bayoedits#bayo2edits#bayo2edit#bayo2#bayonetta2edits#bayonetta2edit#bayonetta2 @_𝔰𝔱𝔞𝔯𝔩0𝔴 @Cal<3 @𝓒𝓮𝓻𝓮𝔃𝓲𝓽𝓪 ྀི @𝓐𝓷𝓴𝓮𝔁 @𝙗𝙪𝙢𝙗𝙤 @𝕾𝖈𝖆𝖗𝖑𝖊𝖙𝖙𝖆 ♡ @🩷🌹₱ink.Møth🦋💖 @6uph0ric @aube @BayonettasFavourite @ezra★★ @Huwicesky_edit @𝙆𝙞𝙣𝙦𝙮𝙞 @Rodrigomv3 @rosa.vspx @𝘷𝘮𝘣𝘳𝘢𝘯
[ #ROSA it’s been soo long since I’ve edited her, missed mother :3 Sp: @Nightie @Bayolina Tags: #bayoedit#bayonettaedits#umbrawitches#viral#bayonetta#umbrawitch#bayoedits#bayo2edits#bayo2edit#bayo2#bayonetta2edits#bayonetta2edit#bayonetta2 @_𝔰𝔱𝔞𝔯𝔩0𝔴 @Cal<3 @𝓒𝓮𝓻𝓮𝔃𝓲𝓽𝓪 ྀི @𝓐𝓷𝓴𝓮𝔁 @𝙗𝙪𝙢𝙗𝙤 @𝕾𝖈𝖆𝖗𝖑𝖊𝖙𝖙𝖆 ♡ @🩷🌹₱ink.Møth🦋💖 @6uph0ric @aube @BayonettasFavourite @ezra★★ @Huwicesky_edit @𝙆𝙞𝙣𝙦𝙮𝙞 @Rodrigomv3 @rosa.vspx @𝘷𝘮𝘣𝘳𝘢𝘯
Artık cidden yeter dayanamıyorum
Artık cidden yeter dayanamıyorum

About

Legal